drugset / Trial / NCT05939674
Effects of Flumazenil on Recovery After Total Intravenous Anesthesia With Remimazolam
RandomizedParallel-groupDouble-blindOther
Summary
Remimazolam is a medication that has the advantage of a short half-life and reversibility with flumazenil. In clinical situations, the use of flumazenil for the reversal of sedation is common, but there is no precise indication for its administration. In this study, we aim to investigate the necessity of routine flumazenil use after administering remimazolam for intravenous anesthesia.
Timeline
- Start
- 2023-09-19
- Primary completion
- 2026-02
- Completion
- 2026-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Flumazenil | Small molecule | 0.3 mg | — |
Indications
No indication recorded.